Latest AI and machine learning research in oncology/hematology for healthcare professionals.
INTRODUCTION: Microvascular invasion (MVI) is one of the most important prognostic factors for hepat...
PURPOSE: Complete mesocolic excision (CME) has been associated with improved oncological outcomes in...
The Ionising Radiation Regulations 2017 requires prior risk assessment calculations and regular envi...
Cell therapies are powerful technologies in which human cells are reprogrammed for therapeutic appli...
BACKGROUND: Pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) has demonstrated ...
Recently, ChatGPT has drawn attention to the potential uses of artificial intelligence (AI) in acade...
Laparoscopic surgery for rectal cancer, while in some respects equivalent or even preferable to open...
BACKGROUND AND PURPOSE: Immunotherapy is a standard treatment for many tumor types. However, only a ...
PURPOSE: To evaluate the image quality and visibility of pancreatic ductal adenocarcinoma (PDAC) in ...
INTRODUCTION: As robotic surgery increases its reach, novel platforms are being released. We present...
BACKGROUND: Deep stromal invasion (DSI) is one of the predominant risk factors that determined the t...
OBJECTIVES: To develop a deep learning (DL) method that can determine the Liver Imaging Reporting an...
Cancer drug response prediction based on genomic information plays a crucial role in modern pharmaco...
Traditional bulk sequencing methods are limited to measuring the average signal in a group of cells,...
BACKGROUND: Early noninvasive screening of patients who would benefit from neoadjuvant chemotherapy ...
The primary aim of this research was to investigate potential differences of breast tumor morphologi...
OBJECTIVES: To develop and validate a CT-based deep learning radiomics nomogram (DLRN) for outcome p...
BACKGROUND: The main application of [18F] FDG-PET ( FDG-PET) and CT images in oncology is tumor iden...
PURPOSE: With the increased use of focal radiation dose escalation for primary prostate cancer (PCa)...
Indoleamine 2,3-dioxygenase 1 (IDO1) is viewed as an extremely promising target for cancer immunothe...